Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 29
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Carcinogenesis ; 33(12): 2424-31, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22948180

RESUMEN

Amarogentin, a secoiridoid glycoside, is an active component of the medicinal plant Swertia chirata. In this study, chemopreventive and chemotherapeutic actions of amarogentin were evaluated in a carbon tetrachloride (CCl(4))/N-nitrosodiethylamine (NDEA)-induced liver carcinogenesis mouse model system during continuous and posttreatment schedule. Better survival, no toxicity and increased body weight were noted in amarogentin-treated mice. Reduction in proliferation and increase in apoptosis frequency were evident in amarogentin-treated groups. In carcinogen control group moderate dysplasia, severe dysplasia and hepatocellular carcinoma were evident at 10th, 20th and 30th week, respectively. Amarogentin was found to prevent progression of liver carcinogenesis at mild dysplastic stage. Exposure to CCl(4)/NDEA resulted in upregulation of ppRb807/811, cyclinD1 and cdc25A at 10th week and additional activation of cMyc and mdm2 along with downregulation of LIMD1, p53 and p21 at 20th week. This was followed by activation of ppRb567 and downregulation of Rbsp3 at 30th week. Prevention of carcinogenesis by amarogentin in both groups might be due to cumulative upregulation of LIMD1, RBSP3, p16 and downregulation of cdc25A at 10th week along with activation of p53 and p21 and downregulation of ppRb807/811 and ppRb567 at 20th week, followed by downregulation of cyclinD1, cMyc and mdm2 at 30th week. During carcinogenesis reduction of apoptosis was evident since 20th week. However, amarogentin treatment could significantly induce apoptosis through upregulation of the Bax-Bcl2 ratio, activation of caspase-3 and poly ADP ribose polymerase cleavage. This is the first report of chemopreventive/therapeutic role of amarogentin during liver carcinogenesis through modulation of cell cycle and apoptosis.


Asunto(s)
Apoptosis/efectos de los fármacos , Puntos de Control del Ciclo Celular/efectos de los fármacos , Fase G1/efectos de los fármacos , Iridoides/farmacología , Neoplasias Hepáticas Experimentales/prevención & control , Fase S/efectos de los fármacos , Animales , Peso Corporal/efectos de los fármacos , Proliferación Celular , Quimioprevención , Femenino , Hígado/patología , Neoplasias Hepáticas Experimentales/mortalidad , Neoplasias Hepáticas Experimentales/patología , Ratones , Fosforilación , Proteína de Retinoblastoma/metabolismo
2.
Food Chem Toxicol ; 50(9): 2996-3003, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22705326

RESUMEN

Tobacco and tea habit are very common in world wide. In the present study, an attempt was made to evaluate the effect of regular drinking of black tea on reactive oxygen species (ROS) generation and DNA damage in buccal cells of normal subjects with or without tobacco habit. Expression of ROS associated proteins IκB, NF-κB as well as DNA repair associated proteins p53, MLH1 were also analyzed. Exfoliated buccal cells were collected from 308 healthy individuals and classified according to age, tobacco and tea habits. In all age groups, comparatively high ROS level and significantly high DNA damage frequency were seen in individuals with tobacco habit than the subjects without tea and tobacco habits. Tea habit effectively lowered ROS level and restrict DNA damage in tobacco users irrespective of ages. The DNA damage seen in the subjects was not associated with apoptosis. Moreover, tea habit effectively lowered the expression of IκB, NF-κB, p53 and MLH1 in tobacco users in all age groups. It seems that regular black tea habit could have anti-genotoxic effect as revealed by reduced tobacco associated ROS generation and DNA damage in buccal cells.


Asunto(s)
Daño del ADN , Mucosa Bucal/metabolismo , Nicotiana , Especies Reactivas de Oxígeno/metabolismo , , Anciano , Ensayo Cometa , Femenino , Humanos , Inmunohistoquímica , Etiquetado Corte-Fin in Situ , Masculino , Persona de Mediana Edad
3.
J Dermatol Sci ; 59(1): 31-9, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20537511

RESUMEN

BACKGROUND: Eugenol is the active component of essential oil isolated from clove (Syzigium aromaticum). Eugenol has antimutagenic, antigenotoxic, anti-inflammatory properties. The anticarcinogenic effect of eugenol was evident in different types of cell lines. However, its anticarcinogenic effect in in vivo has not yet been fully explored. OBJECTIVE: The aim of this study is to evaluate the chemopreventive potential of eugenol in an experimental skin carcinogenesis mice model system. METHOD: Skin tumor was induced by topical application of DMBA croton oil in Swiss mice. To assess the chemopreventive potential of eugenol, it was orally administered 15 days prior carcinogen treatment. The development of skin carcinogenesis was confirmed by histopathological analysis. Cellular proliferation and apoptosis in the skin tumor were analyzed by in situ cellular proliferation and in situ cell death assay. Expression of some proliferation and apoptosis associated genes was analyzed by RT-PCR and protein expression was analyzed by Western blot. RESULTS: Reduction in incidence and sizes of skin tumors along with overall increase in survival of mice were seen due to eugenol treatment. Restriction of skin carcinogenesis at the dysplastic stage along with reduced rate of cellular proliferation and increase in apoptosis were evident in eugenol treated skin tumors. Eugenol treatment led to the downregulation of c-Myc, H-ras and Bcl2 expression along with upregulation of P53, Bax and active Caspase-3 expression in the skin lesions. CONCLUSION: Restriction of skin carcinogenesis at dysplastic stage by eugenol was due to attenuation of c-Myc, H-ras and modification of some p53 associated gene expression.


Asunto(s)
9,10-Dimetil-1,2-benzantraceno/toxicidad , Anticarcinógenos/farmacología , Transformación Celular Neoplásica/efectos de los fármacos , Aceite de Crotón/toxicidad , Eugenol/farmacología , Neoplasias Cutáneas/prevención & control , Animales , Apoptosis/efectos de los fármacos , Caspasa 3/análisis , Transformación Celular Neoplásica/inducido químicamente , Regulación hacia Abajo/efectos de los fármacos , Femenino , Genes myc/efectos de los fármacos , Genes p53/efectos de los fármacos , Genes ras/efectos de los fármacos , Ratones , Proteínas Proto-Oncogénicas/análisis , Proteínas Proto-Oncogénicas c-bcl-2 , Neoplasias Cutáneas/inducido químicamente , Neoplasias Cutáneas/patología , Regulación hacia Arriba/efectos de los fármacos , Proteína X Asociada a bcl-2/análisis
4.
Acta Histochem ; 112(4): 317-27, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19328523

RESUMEN

Cancer chemoprevention is the use of natural, synthetic or biological substances to reverse or prevent the development of cancer. Saffron is a naturally derived plant product that acts as an antispasmodic, diaphoretic, carminative, emmenagogic and sedative. Our aim in this study was to investigate the chemopreventive effect of aqueous saffron on chemically induced skin carcinogenesis using a histopathological approach. Mice were divided into five groups: carcinogen control (CC), normal control (NC) and saffron-treated Groups A, B and C. Groups A, B, C and CC mice received three topical applications of 7,12 dimethylbenz[a]anthracene (DMBA) followed by croton oil on shaven dorsal skin for 8 weeks. NC mice received topical skin applications of the vehicle, acetone, only. Saffron infusion was fed orally to three groups of mice either before (Group A) or after (Group C) or both before and after (Group B) DMBA applications. The activities of antioxidant enzymes glutathione-S transferase (GST), glutathione peroxidase (GPx), catalase (CAT) and superoxide dismutase (SOD) in liver tissue samples taken at 0, 6, 10 and 12 weeks from all groups were assessed. Standard histological examination of skin demonstrated a beneficial action of saffron in mice where saffron treatments were given both before and after the induction of skin carcinogenesis. Saffron ingestion inhibited the formation of skin papillomas in animals and simultaneously reduced their size. In conclusion, saffron inhibits DMBA-induced skin carcinoma in mice when treated early. This may be due, at least in part, to the induction of cellular defense systems.


Asunto(s)
9,10-Dimetil-1,2-benzantraceno/toxicidad , Crocus/química , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/farmacología , Animales , Femenino , Ratones , Papiloma/tratamiento farmacológico , Papiloma/metabolismo , Papiloma/patología , Extractos Vegetales/química , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/metabolismo , Neoplasias Cutáneas/patología
5.
Asian Pac J Cancer Prev ; 11(6): 1445-9, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-21338178

RESUMEN

Swertia chirata is a plant with bitter taste used since an early date in traditional medical systems of our country for treatment of varied human ailments. In Ayurveda, the plant is used as stomachic, febrifuge, antihelminthic, diuretic as well as for treatment of some types of mental disorders. Experimental revalidation of the medicinal properties of this plant along with chemical analysis of its constituents have generated interest in the medicinal value of Swertia chirata and is likely to open up new avenues for its multispectrum use. In view of the antioxidative, anti-inflammatory and anticarcinogenic activities reported in recent times, the plant demands a more detailed probe to determine its use in pharmaceutical industry for preparation of drugs for prevention and treatment of chronic human diseases like diabetes, cardiac problems and cancer. The aim of the present review is to draw attention of researchers in biomedical sciences and pharmaceuticals to this very important plant which has so far not received its due recognition.


Asunto(s)
Medicina Ayurvédica , Neoplasias/tratamiento farmacológico , Fitoterapia , Plantas Medicinales/química , Swertia/química , Animales , Humanos
6.
J Nutr Biochem ; 20(5): 337-49, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-18656336

RESUMEN

The modulatory influence of tea polyphenols (epigallocatechin gallate, epicatechin gallate and theaflavin) on benzo[a]pyrene (B[a]P)-induced lung carcinogenesis in mice was analyzed using histopathological and molecular parameters. Progression of lung lesions was restricted at the hyperplastic stage by tea polyphenols. A significant reduction in cellular proliferative index and an increase in apoptotic index were noted in the restricted lung lesions. High expression of H-ras, c-myc, cyclin D1 and p53 genes was seen at the inflammatory stage (9th week) and in subsequent premalignant lesions, but down-regulation of H-ras at the hyperplastic stage (17th week). Expression of bcl-2 was high in hyperplastic lesions, whereas the expression of mdm2 and bcl-xl increased only at the moderately dysplastic stage (36th week). The tea polyphenols inhibited inflammatory response in the lung lesions on the 9th week, when decreased expression of H-ras and c-myc and increased expression of bax were noted. Prolonged treatment (>9th week) with tea polyphenols resulted in changes in the expression of some additional genes, such as reduced expression of cyclin D1 (from the 17th week), bcl-2 (from the 26th week; mild dysplasia) and p21 (on the 36th week), and high expression of p53 (from the 17th week) and p27 (on the 36th week). These observations indicate that the tea polyphenols can restrict B[a]P-induced lung carcinogenesis by differential modulation of the expression of p53 and its associated genes such as bax, bcl-2, mdm2, p21 and p27, along with H-ras, c-myc and cyclin D1, at different time points.


Asunto(s)
Ciclina D1/biosíntesis , Flavonoides/farmacología , Neoplasias Pulmonares/patología , Fenoles/farmacología , Proteínas Proto-Oncogénicas c-myc/biosíntesis , Proteínas ras/biosíntesis , Animales , Apoptosis/efectos de los fármacos , Benzo(a)pireno , Biflavonoides/farmacología , Catequina/análogos & derivados , Catequina/farmacología , Proliferación Celular/efectos de los fármacos , Transformación Celular Neoplásica/patología , Femenino , Pulmón/patología , Neoplasias Pulmonares/inducido químicamente , Masculino , Ratones , Polifenoles , , Proteína p53 Supresora de Tumor/metabolismo
7.
Asian Pac J Cancer Prev ; 8(2): 263-6, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17696743

RESUMEN

Black tea is more widely consumed than green tea worldwide, particularly in India. Therefore, it is necessary to focus attention on black tea with respect to its health promoting and anti-cancer actions. In order to establish the concept that black tea is a potential candidate for cancer prevention, it is important to provide epidemiological evidence derived from investigations of human populations. In view of this, the objective of the present study was to determine the correlation between nature of black tea consumption and DNA damage in normal subjects with or without tobacco habit and oral cancer patients, taking the latter as positive controls. Much experimental evidence points to associations between tobacco habit and HPV 16 and HPV 18 (Human Papilloma virus) infection. But no studies have taken into account the possible confounding effect of black tea consumption on DNA damage along with HPV infection. A pilot study was therefore undertaken. Comet assay was used to evaluate the DNA damage among normal subjects including tobacco users (n = 86), non-tobacco users (n = 45) and Oral cancer patients (n = 37). Percentage of damaged cells was scored in the buccal squamous cells of all subjects mentioned above. HPV analysis was performed on 79 samples (including 37 oral cancer patients). The evaluation of various confounding factors like age, tenure of tobacco habit and tea habit showed significant associations with DNA damage. The observations strongly indicate that regular intake of black tea at least above four cups can reduce tobacco associated DNA damage among normal tobacco users. HPV prevalence was not seen to be associated with age, tenure of tobacco habit or the tea drinking habit.


Asunto(s)
Alphapapillomavirus/aislamiento & purificación , Daño del ADN , Mucosa Bucal/patología , Mucosa Bucal/virología , Infecciones por Papillomavirus/epidemiología , Fumar/efectos adversos , , Tabaco sin Humo/efectos adversos , Adulto , Ensayo Cometa , Femenino , Humanos , India/epidemiología , Masculino , Persona de Mediana Edad
8.
Apoptosis ; 11(12): 2267-76, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17041754

RESUMEN

The aim of this study was to understand the mode of action of tea polyphenol epigallocatechin gallate (EGCG) in vivo. Swiss albino mice were treated i.p. with EGCG at two different doses i.e. 12-mg/kg body weight and 15-mg/kg body weight, for 7 days prior to inoculation of Sarcoma180 (S180) cells and continued for another 7 days. The growth of the S180, harvested 7 days after inoculation, was significantly reduced due to treatment with EGCG. The flowcytometric analysis of S180 cells, showed significant increase in apoptosis and reduction in the number of cells in G2/M phase of cell cycle due to treatment with EGCG. The induction of apoptosis has also been confirmed by the TUNEL and DNA fragmentation assays. Both RT-PCR and Western blot analysis showed significant up-regulation of p53 and bax, and down-regulation of bcl-2 and c-myc due to EGCG treatment. No changes in the expression pattern of p21, p27, bcl-xl, mdm2 and cyclin D1 were seen. Interestingly, there was significant down-regulation of spliceosomal uridylic acid rich small nuclear RNAs (UsnRNAs) U1B and U4-U6 due to EGCG treatment. This indicates that these UsnRNAs may be involved in the apoptosis process. Taken together, our study suggests that in vivo EGCG could induce apoptosis in S180 cells through alteration in G2/M phase of the cell cycle by up-regulation of p53, bax and down-regulation of c-myc, bcl-2 and U1B, U4-U6 UsnRNAs.


Asunto(s)
Apoptosis/efectos de los fármacos , Catequina/análogos & derivados , ARN Nuclear Pequeño/metabolismo , Sarcoma/patología , Proteína p53 Supresora de Tumor/metabolismo , Animales , Antioxidantes/farmacología , Catequina/farmacología , Ciclo Celular/efectos de los fármacos , Ciclo Celular/genética , Proliferación Celular/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Etiquetado Corte-Fin in Situ , Inyecciones Intraperitoneales , Ratones , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Proteínas Proto-Oncogénicas c-myc/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , ARN Neoplásico/metabolismo , Sarcoma/genética , Proteína X Asociada a bcl-2/metabolismo
9.
Mol Cell Biochem ; 289(1-2): 149-57, 2006 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16718374

RESUMEN

The differential alterations of the spliceosomal UsnRNAs (U1, U2, U4, U5, and U6) were reported to be associated with cellular proliferation and development. The attempt was made in this study to analyze the metabolic pattern of the spliceosomal UsnRNAs during the development of pre-malignant lung lesions induced in experimental mice model system by benzo(a)pyrene (BP) and also to see how tea polyphenols, epigallocatechin gallate (EGCG) and epicatechin gallate (ECG), modulate the metabolism of these UsnRNAs during the lung carcinogenesis. No significant changes in the level of the UsnRNAs were seen in the inflammatory lung lesions at 9th week due to treatment of BP. However, there was significant increase in the level of U1 ( approximately 2.5 fold) and U5 ( approximately 47%) in the hyperplastic lung lesions at 17th week. But in the mild dysplastic lung lesions at 26th week, the level of UsnRNAs did not change significantly. Whereas, in the dysplastic lung lesions at 36th week there was significant increase in the level of the U2 ( approximately 2 fold), U4 ( approximately 2.5 fold) and U5 ( approximately 2 fold). Due to the EGCG and ECG treatment the lung lesions at 9th week appeared normal and in the 17th, 26th, and 36th week it appeared as hyperplasia. The level of the UsnRNAs was significantly low in the lung lesions at 9th week (only U2 and U4 by EGCG), at 17th week (only U1 by EGCG/ECG), at 26th week (U1 by ECG; U2, U4 and U5 by EGCG/ECG) and at 36th week (U1 by ECG, U2 and U4 by EGCG/ECG). Whereas, there was significant increase in the level of U5 (by EGCG/ECG) and U6 (by EGCG only) in the lung lesions at 36th and 26th week respectively. This indicates that the metabolism of the spliceosomal UsnRNAs differentially altered during the development of pre-malignant lung lesions by BP as well as during the modulation of the lung lesions by the tea polyphenols.


Asunto(s)
Flavonoides/farmacología , Neoplasias Pulmonares/inducido químicamente , Fenoles/farmacología , Lesiones Precancerosas/inducido químicamente , ARN Nuclear Pequeño/metabolismo , Empalmosomas/efectos de los fármacos , Empalmosomas/metabolismo , Té/química , Animales , Benzo(a)pireno , Catequina/análogos & derivados , Catequina/farmacología , Pulmón/citología , Pulmón/patología , Neoplasias Pulmonares/patología , Ratones , Polifenoles , Lesiones Precancerosas/patología
10.
Cancer Lett ; 244(2): 252-9, 2006 Dec 08.
Artículo en Inglés | MEDLINE | ID: mdl-16517061

RESUMEN

Swertia chirata, is a bitter plant, used in the Indian system of medicine (Ayurveda) for various human ailments. Our laboratory was the first to report the chemopreventive effect of this plant. The antiproliferative and pro-apoptotic action of amarogentin rich fraction of S. chirata is now demonstrated on a mouse skin carcinogenesis model. Immunohistochemical localization revealed a reduction in proliferating and increase in apoptotic cells in skin lesion following treatment, also reflected in the expression of molecular markers--Cox-II and caspase-3 proteins. It may be possible to calculate relative risk, relative protection and attributable risk from the action of test agents on proliferation and apoptosis.


Asunto(s)
Apoptosis/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Ciclooxigenasa 2/metabolismo , Modelos Animales de Enfermedad , Glucósidos/farmacología , Iridoides/farmacología , Proteínas de la Membrana/metabolismo , Neoplasias Cutáneas/prevención & control , 9,10-Dimetil-1,2-benzantraceno/toxicidad , Animales , Caspasa 3/metabolismo , Regulación hacia Abajo , Electroforesis en Gel de Poliacrilamida , Etiquetado Corte-Fin in Situ , Masculino , Medicina Tradicional , Proteínas de la Membrana/antagonistas & inhibidores , Ratones , Fitoterapia , Extractos Vegetales/uso terapéutico , Neoplasias Cutáneas/inducido químicamente , Neoplasias Cutáneas/patología , Swertia , Regulación hacia Arriba
11.
Carcinogenesis ; 27(8): 1645-54, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16501250

RESUMEN

Spices and flavoring plants part rich in supposedly health-promoting phytochemicals are currently receiving much attention as a possible source of cancer chemopreventive compounds. Clove, the sun-dried unopened flower bud from the plant Syzygium aromaticum L. is a commonly used spice and food flavor. In the present work we assess the chemopreventive potential of aqueous infusion of clove during benzo[a]pyrene (BP)-induced lung carcinogenesis in strain A mice. Incidence of hyperplasia, dysplasia and carcinoma in situ evident in the carcinogen control group on the 8th, 17th and 26th weeks, respectively, were effectively reduced after treatment with clove infusion. Significant reduction in the number of proliferating cells and an increased number of apoptotic cells was also noted in these BP-induced lung lesions following clove treatment. Western blotting analysis revealed that clove infusion upregulates the expression of pro-apoptotic proteins p53 and Bax, and downregulates the expression of anti-apoptotic protein Bcl-2 in the precancerous stages. Expression of caspase 3 and its activation by clove infusion were evident from a very early stage of carcinogenesis (eighth week). Clove infusion was also found to downregulate the expression of some growth-promoting proteins, viz, COX-2, cMyc, Hras. The observations signify the chemopreventive potential of clove in view of its apoptogenic and anti-proliferative properties.


Asunto(s)
Carcinoma in Situ , Quimioprevención , Neoplasias Pulmonares/prevención & control , Syzygium/química , Animales , Animales Recién Nacidos , Apoptosis/efectos de los fármacos , Benzo(a)pireno/toxicidad , Carcinoma in Situ/tratamiento farmacológico , Carcinoma in Situ/prevención & control , Proliferación Celular/efectos de los fármacos , Ciclooxigenasa 2/metabolismo , Femenino , Genes ras/fisiología , Hiperplasia/tratamiento farmacológico , Hiperplasia/prevención & control , Neoplasias Pulmonares/tratamiento farmacológico , Ratones , Extractos Vegetales/farmacología , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Proteína p53 Supresora de Tumor/metabolismo , Proteína X Asociada a bcl-2/metabolismo
12.
Asian Pac J Cancer Prev ; 7(4): 661-6, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17250449

RESUMEN

Lung cancer is one of the leading causes of cancer related death in most developed and many developing countries of the world. Due to lack of validated screening methods and poor prognosis, treatment of lung cancer has not improved significantly over the last two decades. Therefore the risk of the disease needs to be minimized by preventive measures. One approach for lung cancer prevention envisages reversal or restriction of precancerous lesions by chemopreventive intervention. It demands a deeper understanding of the pathogenesis of the disease and identification of the ideal point of intervention. In the present investigation, tea components, epigallocatechin gallate (EGCG) and theaflavins (TF) were assessed for their chemopreventive potential when administered in the post initiation phase of lung carcinogenesis in an experimental mouse model. Histopathological changes in lungs of mice administered benzo(a)pyrene (BP) were followed serially and correlated with the expression of Cox-2, caspase-3 and caspase-7, which play key roles in histopathogenesis of neoplasia. The observations strongly indicate that both EGCG and TF can influence the expression of these genes to modulate the process of carcinogenesis, resulting in delayed onset and lowered incidence of pre-invasive lung lesions.


Asunto(s)
Caspasa 3/metabolismo , Ciclooxigenasa 2/efectos de los fármacos , Flavonoides/farmacología , Neoplasias Pulmonares/prevención & control , Fenoles/farmacología , Té/química , Animales , Animales Recién Nacidos , Benzopirenos , Biflavonoides/farmacología , Western Blotting , Catequina/análogos & derivados , Catequina/farmacología , Proliferación Celular/efectos de los fármacos , Progresión de la Enfermedad , Neoplasias Pulmonares/inducido químicamente , Ratones , Polifenoles
13.
Asian Pac J Cancer Prev ; 6(3): 304-8, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16235990

RESUMEN

Spices and flavouring agents are now receiving increasing attention as many of them have been shown to have anticarcinogenic properties. Cloves, sun-dried unopened flower buds from the plant Syzygium aromaticum L, are commonly used as a spice and food flavour. The present study was designed to investigate the chemopreventive action of aqueous infusion of cloves on 9,10-dimethyl benz(a)anthracene (DMBA) and croton oil induced skin carcinogenesis in Swiss mice. The results indicate protection against skin papilloma formation in a dose dependent manner. It has been shown that oral administration of aqueous infusions of clove at a dose of 100 microl/mouse/day not only delays the formation of papilloma but also reduces the incidence of papilloma as well as the cumulative number of papillomas per papilloma bearing mouse. Our observations suggest a promising role for cloves in restriction of the carcinogenesis process.


Asunto(s)
Transformación Celular Neoplásica/efectos de los fármacos , Quimioprevención , Papiloma/prevención & control , Extractos Vegetales/farmacología , Neoplasias Cutáneas/prevención & control , Syzygium/química , 9,10-Dimetil-1,2-benzantraceno , Administración Oral , Animales , Carcinógenos , Ratones , Neoplasias Experimentales , Papiloma/fisiopatología , Neoplasias Cutáneas/fisiopatología
14.
Asian Pac J Cancer Prev ; 6(3): 326-31, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16235994

RESUMEN

Lung cancer is a complex group of diseases but each lesion is thought to originate from a single mutated progenitor cell. It is evident that multiple genetic changes are involved in the generation of each specific type of lung cancer. Due to the high complexity of these processes and rapid metastasis, treatment of advanced lung cancer, particularly of NSCLCs, is far from satisfactory. Thus, there is a need for innovative strategies for modulation of adverse alteration in protooncogene or tumor suppressor genes so that lung carcinogenesis can be suppressed or delayed. To this end, we have evaluated the effects of tea compounds (theaflavins, epicatechin-gallate and epigallo-catechin-gallate) on proliferation and apoptosis and associated gene expression in a highly metastatic human lung cancer cell line NCI-H460. Significant reduction of cell proliferation, detected in situ by BrdU incorporation, and induction of apoptosis, assessed by the by the TUNEL method, were noted following treatments. Expression of p53, Bcl-2, c-Myc and H-Ras, was localized by immunocytochemistry and analysed by Western blotting. Tea compounds upregulated expression of p53, downregulated expression of Bcl-2 but there was no significant influence on H-ras and c-Myc expressions. It is suggested that tea compounds can influence genetic alteration to disfavour, growth and survival of lung cancer cells.


Asunto(s)
Flavonoides/farmacología , Neoplasias Pulmonares/patología , Metástasis de la Neoplasia , Fenoles/farmacología , , Apoptosis/efectos de los fármacos , Western Blotting , Proliferación Celular/efectos de los fármacos , Regulación hacia Abajo , Genes bcl-2 , Genes p53 , Humanos , Inmunohistoquímica , Etiquetado Corte-Fin in Situ , Polifenoles , Células Tumorales Cultivadas
15.
J Environ Pathol Toxicol Oncol ; 24(3): 211-24, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16050805

RESUMEN

Lung cancer has emerged as one of the leading causes of cancer death in most developed and many developing countries of the world. In the absence of effective screening and early detection methods of lung cancer and overall poor prognosis, the 5-year survival following treatment has not improved significantly over the last two decades. It is hoped that the risk of the disease can be minimized by preventive measures. One aspect of lung cancer prevention emphasizes the cessation of tobacco smoking, and another strategy envisages reversal or restriction of the process of lung carcinogenesis by chemopreventive intervention. The latter strategy, however, demands a deeper understanding of the pathogenesis of the disease and the identification of the ideal point of intervention. In the present investigation, we assessed the role of the antioxidant tea components theaflavins (TF) and epigallocatechin gallate (EGCG) for their chemopreventive potential and molecular mechanism of action when administered at the post-initiation phase of lung carcinogenesis in an experimental mouse model. We serially examined the histopathological changes in the lung of mice administered benzo(a)pyrene and correlated them with the frequency of proliferative and apoptotic cells in situ as well as with the expression of H-ras, c-Myc, p53, and Bcl-2 genes, which play key roles in the histopathogenesis of neoplasia. Our findings indicate that both TF and EGCG can influence gene expression to modulate the process of carcinogenesis through the regulation of apoptosis. This results in a lowered incidence and delayed onset of preinvasive lung lesions.


Asunto(s)
Carcinoma in Situ/metabolismo , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Neoplasias Pulmonares/prevención & control , Pulmón/metabolismo , Proteínas Proto-Oncogénicas/genética , Proto-Oncogenes , , Animales , Animales Recién Nacidos , Anticarcinógenos/uso terapéutico , Apoptosis/efectos de los fármacos , Benzo(a)pireno/toxicidad , Biflavonoides/uso terapéutico , Carcinoma in Situ/genética , Carcinoma in Situ/patología , Catequina/análogos & derivados , Catequina/uso terapéutico , Proliferación Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Femenino , Hiperplasia , Pulmón/efectos de los fármacos , Pulmón/patología , Masculino , Ratones , Extractos Vegetales/uso terapéutico , Proteínas Proto-Oncogénicas/metabolismo , Té/química
16.
J Environ Pathol Toxicol Oncol ; 23(4): 287-96, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15511216

RESUMEN

Carbon tetrachloride (CCl(4)) is a known hepatotoxic compound working through the generation of reactive free radicals. Selenium (Se) is an essential trace element required by animals and humans for protection against xenobiotic compounds. In this study, Se, as diphenylmethyl selenocyanate, has been evaluated for its protective action against CCl(4)-induced hepatotoxicity in Swiss albino mice. Treatment with Se compound was found to upregulate different phase II detoxifying enzymes (catalase, superoxide dismutases, reduced glutathione, and glutathione transferase) in liver of mice challenged with different doses of CCl(4) as compared to the CCl(4) control, when measured after 24 hours of CCl(4) treatment (p < 0.01). The Se compound also significantly (p < 0.01) inhibited the level of membrane lipid peroxidation and serum transferase activity (ALT and AST) in the treated group as compared to the control group.


Asunto(s)
Tetracloruro de Carbono/toxicidad , Enfermedad Hepática Inducida por Sustancias y Drogas/prevención & control , Compuestos de Organoselenio/uso terapéutico , Sustancias Protectoras/uso terapéutico , Alanina Transaminasa/sangre , Animales , Aspartato Aminotransferasas/sangre , Catalasa/sangre , Enfermedad Hepática Inducida por Sustancias y Drogas/sangre , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Femenino , Glutatión/sangre , Glutatión Transferasa/sangre , Peroxidación de Lípido , Ratones , Microsomas Hepáticos/efectos de los fármacos , Microsomas Hepáticos/enzimología , Microsomas Hepáticos/metabolismo , Distribución Aleatoria , Superóxido Dismutasa/sangre
17.
Asian Pac J Cancer Prev ; 5(2): 126-32, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15244513

RESUMEN

The major food items of Indian cuisine include rice, wheat, diary products, and abundant fruits and vegetables. Beside these, there are several kinds of herbs and spices as important ingredients, containing many phytochemicals with medicinal properties, adding taste to Indian cuisine. An impressive body of data exists in support of the concept that Indian food ingredients can be used in preventive strategies aimed at reducing the incidence and mortality of different types of cancers because of their antioxidative, antimutagenic and anticarcinogenic properties. Vital ingredients used in Indian cooking include turmeric, cloves, ginger, aniseed, mustard, saffron, cardamom and garlic Garlic is an indispensable ingredient of Indian food and this report concerns the chemopreventive efficacy of garlic in an azoxymethane induced rodent colon carcinogenesis model. The effect of garlic was evaluated in terms of aberrant crypt foci, putative preneoplastic lesions in the colon. In addition, cell proliferation and levels of apoptosis were determined and the expression of cyclooxygenase-2 protein was analyzed. Following treatment, significant inhibition of cell proliferation and induction of apoptosis, as well as suppression of cyclooxygenase-2 activity were observed, associated with significant reduction in the incidence of aberrant crypt foci. The study points to combined protective effects of garlic components on colon carcinogenesis.


Asunto(s)
Neoplasias del Colon/prevención & control , Dieta , Ajo , Isoenzimas/metabolismo , Prostaglandina-Endoperóxido Sintasas/metabolismo , Análisis de Varianza , Animales , Antioxidantes/farmacología , Apoptosis/efectos de los fármacos , Western Blotting , División Celular/efectos de los fármacos , Neoplasias del Colon/enzimología , Neoplasias del Colon/patología , Técnicas de Cultivo , Ciclooxigenasa 2 , Modelos Animales de Enfermedad , India , Isoenzimas/análisis , Masculino , Probabilidad , Prostaglandina-Endoperóxido Sintasas/análisis , Ratas , Ratas Sprague-Dawley , Valores de Referencia , Sensibilidad y Especificidad
18.
Phytother Res ; 18(5): 373-8, 2004 May.
Artículo en Inglés | MEDLINE | ID: mdl-15173996

RESUMEN

Considerable attention has been focused on plants which are sources of natural anti-oxidant compounds, because most of them have a modulatory role on physiological functions and biotransformation reactions involved in the detoxification process. Such compounds are likely to afford protection from cytotoxic, genotoxic and metabolic actions of environmental toxicant thereby reducing the risk for cancer. The present study reports the anticarcinogenic activity of Swertia chirata Buch.Ham, an Indian medicinal plant. All the four detoxification enzymes studied viz, GST, GPx, SOD and CAT were found to be activated in different degrees following treatment with infusion of Swertia chirata, its crude extract and a purified 'Amarogentin' rich extract. The activation of the enzymes was accompanied by significant reduction in lipid peroxidation and inhibition of incidence as well as multiplicity of Dimethylbenz(a)anthracene (DMBA) induced papillomas. The effect of S.chirata on apoptosis and cell proliferation was also studied in mice skin exposed to DMBA. Both the crude and purified extracts significantly inhibited cell proliferation and induced apoptosis. This is the fi rst report of its kind and the observation suggests the chemopreventive potential of Swertia chirata.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Papiloma/prevención & control , Fitoterapia , Extractos Vegetales/farmacología , Neoplasias Cutáneas/prevención & control , Swertia , 9,10-Dimetil-1,2-benzantraceno , Animales , Antineoplásicos Fitogénicos/administración & dosificación , Antineoplásicos Fitogénicos/uso terapéutico , Apoptosis , División Celular , India , Masculino , Medicina Tradicional , Ratones , Papiloma/inducido químicamente , Papiloma/patología , Extractos Vegetales/administración & dosificación , Extractos Vegetales/uso terapéutico , Neoplasias Cutáneas/inducido químicamente , Neoplasias Cutáneas/patología
19.
Cancer Lett ; 208(2): 127-36, 2004 May 28.
Artículo en Inglés | MEDLINE | ID: mdl-15142670

RESUMEN

Preventive intervention of colorectal cancer has become essential as a major portion of the population may develop the disease at some points during their lives. Diet and nutrition play an important role during this multistep colon carcinogenic process. Inhibitory activity of aqueous suspensions of garlic and tomato, individually and in combination, were tested on azoxymethane induced colon carcinogenesis in Sprague-Dawley rats. The effect was observed on aberrant crypt foci (ACF), the preneoplastic lesion. To investigate the mechanism of action of the agents used, cell proliferation and the level of apoptosis were determined and the expression of cyclooxygenase-2 (COX-2) protein was analyzed in the colon. Following treatment, significant inhibition of the level of cell proliferation (P<0.01 in garlic; P<0.001 in tomato and P<0.001 in combination treatment group with respect to the carcinogen control group), significant induction of apoptosis (P<0.01 in garlic treated; P<0.01 in tomato treated and P<0.001 in combination treatment group with respect to the carcinogen control group) and suppression of COX-2 expression among the treated groups resulted in significant reduction in the incidences of ACF (by 45.27% in garlic, 68.24% in tomato and 71.62% in combination treatment group). The preventive effect was better when the combination of garlic and tomato was administered in comparison to the individual treatment groups, suggesting the synergistic action of garlic and tomato.


Asunto(s)
Apoptosis , Neoplasias del Colon/prevención & control , Ajo , Isoenzimas/metabolismo , Lesiones Precancerosas/prevención & control , Prostaglandina-Endoperóxido Sintasas/metabolismo , Animales , Azoximetano , División Celular , Neoplasias del Colon/enzimología , Neoplasias del Colon/patología , Ciclooxigenasa 2 , Solanum lycopersicum , Masculino , Ratas , Ratas Sprague-Dawley
20.
Asian Pac J Cancer Prev ; 5(1): 15-23, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15074999

RESUMEN

Research in cancer chemoprevention involves a number of activities, the first and foremost of which is acquisition of detailed knowledge concerning the process of carcinogenesis and identification of points of intervention whereby the process can be reversed or stalled. Parallel to this is the search for ideal chemopreventive agents--natural or synthetic--and screening for their activity and efficacy in vitro and in vivo. For ethical reasons it is not possible to test new agents on humans, so preclinical studies are dependent on results first being obtained with suitable animal models. Since it is not possible for a single model to reflect the diversity and heterogeneity of human cancers, it is necessary to have as many different models as possible, depending on the requirement of the studies on different aspects of cancer biology. Advances in research on carcinogenesis and chemoprevention therefore have to be accompanied by development of appropriate laboratory animal models using a variety of carcinogens that produce tumours at different sites. Animal models have contributed significantly to our understanding of carcinogenesis and ways to intervene in the underlying processes. Many animal carcinogenesis and tumour models have been found to mirror corresponding human cancers with respect to cell of origin, morphogenesis, phenotype markers and genetic alteration. In spite of the fact that interpolation of data from animal studies to humans is difficult for various reasons, animal models are widely used for assessment of new compounds with cancer chemopreventive potential and for preclinical trials. So despite the movements of animal rights activists, animal models will continue to be used for biomedical research for saving human lives. In doing so, care should be taken to treat and handle the animals with minimal discomfort to them and ensuring that alternatives are used whenever possible.


Asunto(s)
Anticarcinógenos/farmacología , Quimioprevención , Modelos Animales de Enfermedad , Alternativas a las Pruebas en Animales , Bienestar del Animal , Animales , Apoptosis , Diferenciación Celular , Transformación Celular Neoplásica , Humanos , Fenotipo , Reproducibilidad de los Resultados
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...